ACADEMY OF MANAGED CARE PHARMACY

Lobbying for ACADEMY OF MANAGED CARE PHARMACY · Professional association representing managed care pharmacy

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Nov 4, 2026

Expenses

$180,000

What this organization spent lobbying with its own staff. Reported using IRS section 162(e) definitions (method C): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 5

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Medicare/Medicaid

Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act/Main Street Pharmacy Access Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding

Pharmacy

Access to PDTs Act - Medicare/Medicaid coverage of prescription digital therapeutics Medicaid VBPs for Patients Act - Codifying Medicaid Multiple Best Price Rule Ensuring Access to Pharmacist Services Act - Medicare Part B payment for certain pharmacist-administered services General support for Medicaid funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.